Life Sciences Baltics 2016 is the only international forum in the Baltics for world-class biotechnology, pharmaceutical and medical devices experts from all around the world. It provides a unique opportunity to explore the new horizons of partnerships, exchange ideas and seek progress through networking. Discover enormous potential and passion in the field of life sciences in Lithuania and the Baltics – the gateway to emerging markets.
- Discover state-of-the-art scientific infrastructure and investor-ready startups in the Baltics
- Meet Nobel prize winners, 800 key sector players and decision makers from more than 30 countries
- Learn about EU strategic directions and funding opportunities
- Tell the world about your discovery at the international conference, exhibition and networking events.
Life Sciences Baltics 2016 Agenda
- International Conference and Seminars
Nobel Prize laureate, world-class speakers, prominent figures and organizations, high level public officials and regulatory bodies, leading life sciences experts and key corporate players.
- B2B Partnership Event
Pre-scheduled individual meetings among forum participants.
- International Exhibition
A great one-stop-shop to meet key sector players, associated manufacturers and service providers.
- Company Visits
Visits to Lithuanian life sciences industry companies and R&D centers to provide hands-on experience and learn more about the cooperation potential.
Start-up pitch session for investors.
- Social Programme
Welcome cocktail, Gala dinner, sightseeing tours and other social events, providing additional opportunity for networking.
- Baltics are uniquely located to comfortably act as a crossroad bridge between East and West.
- Region offers highly qualified talent pool as well as astonishing tax environment for R&D.
- A growing number of start-ups and SMEs have advanced product portfolio and would like to attract partners for the financial investments.
- Cooperation with Baltic companies enables access to the EU structural funds (only in Lithuania up to 1 billion EUR for the period of 2014-2020).
- Gross salaries in the life sciences sector are 2 to 3 times more competitive compared to Western Europe.
- Lithuania is investing 400 million EUR in 5 research valleys to become one of the top high tech innovation centres in Europe.
- Europe‘s prime location and infrastructure: crossroads of North, East and West; 3 Pan-European transport corridors; 4 modern international airports.
Life Sciences Baltics 2014 Highlights
- More than 1000 life sciences sector key players and decision makers from more than 40 countries (Main countries: Israel, USA, UK, Germany, Sweden, Japan, Oman), regulatory bodies and government representatives. Participants by sectors: 23% Biotech; 16% Pharma; 16% Medical devices; 5% Lasers; 12%Consulting; 12% Non-profit/public organisations; 16% other.
- More than 80 lectors at the international LSB2014 conference and MAP Kinases II conference.
- 56 companies and universities at the international exhibition.
- More than 450 participants at the b2b partnership event.
- 21 start-ups in start-up programme.
- 250 participants visited 15 Lithuanian companies and universities.
- Intel Business Challenge Europe 2014 finals with 24 best teams from Europe.
When? 14-15th September 2016
[iconbox_top icon=”PDF_Document.png”]Program Life Science Baltic [/iconbox_top]